Skip to main content
SpringerLink
Log in

Therapieadhärenz bei Schizophrenie-Patienten

  • Übersicht
  • Published:
Psychiatrie und Psychotherapie

Summary

The extent to which patients adhere to recommended therapeutic measures is one of the key challenges for all medical disciplines [1]. It concerns all pharmacological and nonpharmacological therapies. It is a well known fact that patients with psychiatric disorders have great difficulties to adhere to therapeutic regimens. On the other hand they would substantially profit from adhering to medication [2, 3]. This manuscript focuses on treatment adherence in patients suffering from schizophrenia. As adherence problems with regard to the regular intake of medication is one of the key problems in the management of schizophrenia [4] we focus on this specific aspect.

Zusammenfassung

Das Ausmaß, in dem Patienten den ihnen verordneten und empfohlenen Behandlungsmaßnahmen folgen, ist eines der wichtigsten Anliegen eines jeden medizinischen Fachgebiets [1] und betrifft generell alle pharmakologischen und nicht-pharmakologischen therapeutischen Angebote. Patienten mit psychischen Erkrankungen haben bekanntermaßen große Schwierigkeiten, einem medikamentösen Behandlungsregime zu folgen, aber auch das größte Potenzial, von der medikamentösen Adhärenz zu profitieren [2, 3]. In der vorliegenden Publikation wird die Therapieadhärenz bei Patienten mit Schizophrenie beleuchtet. Da suboptimale Adhärenz hinsichtlich Einnahme der Medikation eines der Hauptprobleme in der Behandlung von schizophrenen Patienten darstellt [4], wird im vorliegenden Strategiepapier vor allem die medikamentöse Therapieadhärenz abgehandelt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Osterberg L., Blaschke T.: Adherence to medication. N Engl J Med; 353, 487–497 (2005)

    Article  PubMed  CAS  Google Scholar 

  2. Zygmunt A., Olfson M., Boyer CA., Mechanic D.: Interventions to improve medication adherence in schizophrenia. Am J Psychiatry; 159, 1653–1664 (2002)

    Article  PubMed  Google Scholar 

  3. Nose M, Barbui C, Gray R, Tansella M.: Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry; 183, 197–206 (2003)

    Article  PubMed  Google Scholar 

  4. Kikkert MJ, Schene AH, Koeter MWJ et al.: Medication adherence in schizophrenia: exploring patients´, carers´ and professionals´ views. Schizophrenia Bulletin; 32, 786–794 (2006)

    Article  PubMed  Google Scholar 

  5. [WHO 2003] World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, 2003.

  6. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis; 30 (Suppl. 2):S171-176, 2000.

  7. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr; 31(Suppl. 3):S98-102, 2002.

    Google Scholar 

  8. Kemp R, Hayward D, David A.: Compliance Therapy Manual. Institute of Psychiatry, London (1997)

    Google Scholar 

  9. Coldham EL, Addington J, Addington D.: Medication adherence of in-dividuals with a first episode of psychosis. Acta Psychiatr Scand; 106, 286–290 (2002)

    Article  PubMed  CAS  Google Scholar 

  10. Fleischhacker WW, Hofer A, Hummer M.: Managing Schizophrenia: The Compliance Challenge Second edition. Current Medicine Group, London (2007)

    Google Scholar 

  11. Weiden PJ, Olfson M.: Cost of relapse in schizophrenia. Schizophr Bull; 21, 419–429 (1995)

    PubMed  CAS  Google Scholar 

  12. Novick D, Haro JM, Suarez D et al.: Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Research; 176, 109–113 (2010)

    Article  PubMed  Google Scholar 

  13. Ascher-Svanum H, Zhu B, Faries D et al.: A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry; 67, 1114–1123 (2006)

    Article  PubMed  Google Scholar 

  14. Fleischhacker WW, Oehl MA, Hummer M. Factors influencing compliance in schizophrenia patients. J Clin Psychiatry; 64(Suppl. 16):10–13, 2003.

    Google Scholar 

  15. Rettenbacher MA, Hofer A, Eder U et al.: Compliance in schizophrenia: psychopathology, side effects, and patients’ attitudes toward the illness and medication. J Clin Psychiatry; 65, 1211–1218 (2004)

    Article  PubMed  Google Scholar 

  16. Rittmannsberger H, Pachinger T, Keppelmuller P et al.: Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatric Services; 55, 174–179 (2004)

    Article  PubMed  Google Scholar 

  17. Robinson DG, Woerner MG, Alvier JM et al.: Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research; 57, 209–219 (2002)

    Article  PubMed  Google Scholar 

  18. Olfson M, Mechanic D, Hansell S et al.: Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv; 51, 216–222 (2000)

    Article  PubMed  CAS  Google Scholar 

  19. Day JC, Bentall RP, Roberts C et al.: Attitudes toward antipsychotic medication. The impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry; 62, 717–724 (2005)

    Article  PubMed  Google Scholar 

  20. Zolnierek KB, DiMatteo MR.: Physician communication and patient adherence to treatment: a meta-analysis. Med Care; 47, 826–834 (2009)

    Article  PubMed  Google Scholar 

  21. Makoul G, Arntson P, Schofield T.: Health promotion in primary care: physician-patient communication and decision making about prescription medication. Social Science and Medicine; 41, 1241–1254 (1995)

    Article  PubMed  CAS  Google Scholar 

  22. Stevenson FA, Cox K, Britten N et al.: A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expectations; 7, 235–245 (2004)

    Article  PubMed  Google Scholar 

  23. Bayle FJ, Chauchot F, Maurel M et al.: Survey on the announcement of schizophrenia diagnosis in France. L’ Encephale; 25, 603–611 (1999)

    CAS  Google Scholar 

  24. Gray R, Rofail D, Allen J et al.: A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. Journal of Advanced Nursing; 52, 31–37 (2005)

    Article  PubMed  Google Scholar 

  25. Hummer M, Fleischhacker WW. Management strategies for patients who show poor compliance. In: Switching Antipsychotic Medication. Edited by SR Marder. London: Science Press:21-28, 2000.

  26. Meise U, Kurz M, Fleischhacker WW: Antipsychotic maintenance treatment of schizophrenic patients: is there a consensus?. Schizophr Bull; 20, 215–225 (1994)

    PubMed  CAS  Google Scholar 

  27. Miller AL, Crismon ML, Rush AJ et al.: The Texas medication algorithm project: clinical results for schizophrenia. Schizophr Bull; 30, 627–647 (2004)

    PubMed  Google Scholar 

  28. Di Matteo MR, Sherbourne CD, Hays RD et al.: Physician’s characteristics influence patients’ adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol; 12, 93–102 (1993)

    Article  CAS  Google Scholar 

  29. Claxton AJ, Cramer J, Pierce C.: A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics; 23, 1296–1310 (2001)

    Article  PubMed  CAS  Google Scholar 

  30. Bull SA, Hu XH, Hunkeler EM et al.: Discontinuation of use and switching antidepressants: influence of patient-physician communication. JAMA; 288, 1403–1409 (2002)

    Article  PubMed  Google Scholar 

  31. Lambert M, Conus P, Eide P et al.: Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry; 19, 415–422 (2004)

    Article  PubMed  CAS  Google Scholar 

  32. Demyttenaere K, Enzlin P, Dewe W. Compliance with antidepressants in a primary care setting. 1: Beyond lack of efficacy and adverse events. Journal of Clinical Psychiatry; 62(Suppl. 22):30-33, 2001.

    Google Scholar 

  33. Hummer M, Fleischhacker WW. Compliance and outcome in patients treated with antipsychotics. The impact of extrapyramidal syndromes. CNS Drugs; 5(Suppl 1):13-20, 1996.

    Google Scholar 

  34. Hummer M, Kemmler G, Kurz M et al.: Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry; 156, 631–633 (1999)

    PubMed  CAS  Google Scholar 

  35. Kurzthaler I, Fleischhacker WW. The clinical implications of weight gain in schizophrenia. J Clin Psychiatry; 62(Suppl 7):32–37, 2001.

    Google Scholar 

  36. Roose SP. Compliance: the impact of adverse events and tolerability on the physician´s treatment decisions. European Neuropsycho pharmacology; 13(Suppl. 3):S85-S92, 2003.

    Google Scholar 

  37. Ritchie CW, Harrigan S, Mastwyk M et al.: Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3(1/2) years duration. Int J Geriatr Psychiatry; 25, 411–418 (2010)

    Article  PubMed  CAS  Google Scholar 

  38. Musalek M.: Social aesthetics and the management of addiction. Curr Opin Psychiatry; 23, 530–535 (2010)

    Article  PubMed  Google Scholar 

  39. Hummer M, Fleischhacker WW. Ways of improving compliance. In: Difficult Clinical Problems in Psychiatry. Edited by M Lader, D Naber. London: Martin Dunitz: 229-264, 1999.

  40. Lieberman JA, Sheitman B, Chakos M, et al. The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol; 18(Suppl. 1):S20-24, 1998.

    Google Scholar 

  41. Robinson DG, Woerner MG, Alvir JM et al.: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry; 56, 241–247 (1999)

    Article  PubMed  CAS  Google Scholar 

  42. Fenton WS, Blyler C, Heinssen RK.: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull; 23, 637–651 (1997)

    PubMed  CAS  Google Scholar 

  43. Hamann J, Cohen R, Leucht S et al.: Shared decision making and long-term outcome in schizophrenia treatment. J Clin Psychiatry; 68, 992–997 (2007)

    Article  PubMed  Google Scholar 

  44. Irani F, Dankert M, Brensinger C et al.: Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology; 29, 960–968 (2004)

    Article  PubMed  Google Scholar 

  45. Bultman DC, Svarstad BL.: Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Education and Counseling; 40, 173–185 (2000)

    Article  PubMed  CAS  Google Scholar 

  46. Gray R, White J, Schulz M, Abderhalden C.: Enhancing medication adherence in people with schizophrenia: an international programme of research. Int J Ment Health Nurs; 19, 36–44 (2010)

    Article  PubMed  Google Scholar 

  47. Love RC. Strategies for increasing treatment compliance: the role of long-acting antipsychotics. Am J Health Syst Pharm; 59(Suppl. 8):S10-S15, 2002.

    Google Scholar 

  48. Leucht S, Heres S, Kissling W, Davis JM. Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol Jan 6:1-16 (Epub ahead of print), 2011.

    Google Scholar 

  49. Heres S, Schmitz FS, Leucht S, Pajonk FG.: The attitude of patients towards antipsychotic depot treatment. Int Clin Psychopharmacol 22, 275–282 (2007)

    Article  PubMed  Google Scholar 

  50. [ADHES 2010] The adherence challenge in psychosis: is it the same throughout Europe, the Middle East and Africa? Educational Meeting, Düsseldorf, Germany, 18 June 2010.

  51. Thompson K, Kulkarni J, Sergejew AA.: Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res; 42, 241–247 (2000)

    Article  PubMed  CAS  Google Scholar 

  52. Stone MS, Bronkesh SJ: Meshing patient and physician goals, (www.hsmgroup.com/info/compli/compli.html), 1998.

  53. Rothenhäusler HB, Täschner KL.: Kompendium Praktische Psychiatrie. Springer, Wien/New York (2007)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department für Psychiatrie und Psychotherapie, Medizinische Universität Innsbruck, Anichstraße 35, 6020, Innsbruck, Österreich

    W. Wolfgang Fleischhacker

  2. Fachärztin für Psychiatrie und psychotherapeutische Medizin, Wien, Österreich

    Christine Allen

  3. 6. Psychiatrische Abteilung, Sozialmedizinisches Zentrum Baumgartner Höhe, Otto-Wagner-Spital und Pflegezentrum, Wien, Österreich

    Andreas Erfurth

  4. Universitätsklinik für Biologische Psychiatrie, Department für Psychiatrie und Psychotherapie, Medizinische Universität Innsbruck, Innsbruck, Österreich

    Alex Hofer

  5. Landesnervenklinik Sigmund Freud, Graz, Österreich

    Michael Lehofer

  6. Abteilung Psychiatrie und Psychotherapie A, Landeskrankenhaus Hall, Tirol, Österreich

    Josef Marksteiner

  7. Anton Proksch Institut Wien, Wien, Österreich

    Michael Musalek

  8. Psychosozialer Dienst, Wien, Österreich

    Georg Psota

  9. Universitätsklinik für Psychiatrie, Medizinische Universität Graz, Graz, Österreich

    Hans-Bernd Rothenhäusler

  10. Landes-Nervenklinik Wagner-Jauregg, Linz, Österreich

    Werner Schöny

  11. Universitätsklinik für Psychiatrie und Psychotherapie l, Christian-Doppler-Klinik, Paracelsus Medizinische Privatuniversität, Salzburg, Österreich

    Christoph Stuppäck

  12. Klinische Abteilung für Sozialpsychiatrie, Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien, Wien, Österreich

    Johannes Wancata

Authors
  1. W. Wolfgang Fleischhacker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andreas Erfurth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alex Hofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Lehofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Josef Marksteiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Musalek
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Georg Psota
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hans-Bernd Rothenhäusler
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Werner Schöny
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Christoph Stuppäck
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Johannes Wancata
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Wolfgang Fleischhacker.

Additional information

Eingegangen am 6. Juli 2011, angenommen am 1. September 2011

Treatment adherence in schizophrenia patients

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolfgang Fleischhacker, W., Allen, C., Erfurth, A. et al. Therapieadhärenz bei Schizophrenie-Patienten. psychiatr. psychother. 7, 98–109 (2011). https://doi.org/10.1007/s11326-011-0170-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11326-011-0170-9

Keywords

Schlüsselwörter

Search

Navigation